Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Jump to content
Independent

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Swipe for next article

Independent Bulletin homepage

Download our
Social Partner

We are 8 logo (opens in a new tab)We are 8 logoWe are 8 logo
  1. All
  2. News
  3. Sport
  4. Culture
  5. Lifestyle

Trump funding cuts harming HIV patients, WHO says

James fear he might die after failing to find HIV/AIDS medication for nearly two months - Uganda
James fear he might die after failing to find HIV/AIDS medication for nearly two months - Uganda (Bel Trew)
  • The World Health Organization (WHO) warns that cuts to USAID funding for HIV/AIDS programs, initiated by the Trump administration, are causing drug shortages and increasing the risk of drug resistance.
  • Millions of people, particularly in sub-Saharan Africa, rely on dolutegravir (DTG), a crucial HIV drug now in short supply. Experts predict a significant rise in drug resistance if shortages continue, jeopardising long-term HIV control.
  • The WHO expresses concern about the lack of a readily available, affordable, and equally effective alternative to DTG, especially for vulnerable populations like children and pregnant women.
  • The funding cuts have led to clinic closures and treatment interruptions, exacerbating the risk of infections and drug-resistant strains.
  • While the US State Department claims that life-saving HIV services are ongoing and under review, there's no confirmation of funding restoration, leaving millions at risk.
In full

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in